Lmr Partners LLP Edwards Lifesciences Corp Transaction History

Lmr Partners LLP

$18.1 Billion
Q3 2025

A detailed history of Lmr Partners LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lmr Partners LLP holds 6,887 shares of EW stock, worth $594,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,887

Holding current value

$594,348

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$73.75 - $81.83 $507,916 - $563,563	6,887 New	6,887 $535,000
Q1 2025 May 15, 2025	SELL	$67.95 - $76.19 $2.46 Million - $2.76 Million	-36,171 Reduced 27.07%	97,472 $7.06 Million
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $8.63 Million - $10.1 Million	133,643 New	133,643 $9.89 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $6.29 Million - $8.28 Million	86,648 New	86,648 $8.28 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $637,379 - $830,210	-7,738 Reduced 45.95%	9,103 $752,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $1.46 Million - $2.16 Million	16,841 New	16,841 $1.6 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $230,078 - $282,660	-2,163 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $1.69 Million - $2.02 Million	-16,445 Reduced 88.38%	2,163 $245,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $930,288 - $1.16 Million	11,096 Added 147.71%	18,608 $1.93 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $591,044 - $681,113	7,512 New	7,512 $628,000
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $645,695 - $840,298	-9,610 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $552,959 - $739,489	9,610 New	9,610 $664,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $691,445 - $1.07 Million	-13,193 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $945,938 - $1.08 Million	13,193 New	13,193 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $532,469 - $652,544	-8,651 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $482,206 - $557,210	8,651 New	8,651 $1.6 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $329,770 - $441,048	-6,886 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $319,579 - $392,088	6,886 New	6,886 $1.06 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $206,015 - $261,599	-4,508 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$42.45 - $51.3 $109,351 - $132,148	2,576 Added 133.33%	4,508 $656,000
Q4 2017 Jan 30, 2018	SELL	$33.79 - $39.39 $150,737 - $175,718	-4,461 Reduced 69.78%	1,932 $218,000
Q3 2017 Nov 09, 2017	BUY	$36.29 - $38.83 $232,001 - $248,240	6,393	6,393 $698,000

Others Institutions Holding EW

# of Institutions

1,457

Shares Held

468M

Call Options Held

3.49M

Put Options Held

4.09M

Vanguard Group Inc Valley Forge, PA

70.4M
Shares

$6.07 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$4.4 Billion
0.11% of portfolio
State Street Corp Boston, MA

25.6M
Shares

$2.21 Billion
0.07% of portfolio
Jpmorgan Chase & CO New York, NY

25.1M
Shares

$2.16 Billion
0.13% of portfolio
Wellington Management Group LLP Boston, MA

20.8M
Shares

$1.8 Billion
0.3% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account